Central Dogma

framework · biology · formal-scientific

Crick's framework of information flow from DNA to RNA to protein.

The Central Dogma of Molecular Biology was articulated by Francis Crick in 1958 (in his paper 'On Protein Synthesis', Symposia of the Society for Experimental Biology) and clarified in his 1970 Nature paper 'Central Dogma of Molecular Biology'. The framework specifies the direction of sequence information transfer in biological systems: information flows from nucleic acid (DNA, RNA) to nucleic acid and from nucleic acid to protein, but not from protein back to nucleic acid sequence. The dogma's specific claim is about sequence information transfer, not regulatory or other influence. The standard pathway: DNA replicates (DNA→DNA); DNA is transcribed to RNA (DNA→RNA); RNA is translated to protein (RNA→protein). Specific 'unusual' pathways were anticipated by Crick and have been subsequently confirmed: reverse transcription (RNA→DNA, discovered by Temin and Baltimore 1970, foundation of retrovirology and contemporary mRNA vaccine technology); RNA replication (RNA→RNA, in many viruses). Crick's framework is sometimes misstated as 'DNA makes RNA makes protein' — the actual claim is more precisely about which information transfers are possible. The framework has been substantially robust to subsequent discoveries: alternative splicing, RNA editing, post-translational modification, prions (which propagate conformational rather than sequence information), and epigenetic inheritance through DNA methylation and chromatin marks all add complexity but don't violate the central dogma's specific sequence-transfer claims. The framework remains foundational to molecular biology and is the conceptual backbone of contemporary biotechnology, including PCR, sequencing, recombinant DNA, gene therapy, and mRNA vaccine platforms.

Originators

Francis Crick (foundational 1958, clarified 1970); Howard Temin and David Baltimore (independent discovery of reverse transcription, 1970) high

Year / Decade

1958 (Crick foundational); 1970 (Crick clarification; Temin-Baltimore reverse transcription) high

Primary sources

Crick, F. (1958). 'On Protein Synthesis', Symposia of the Society for Experimental Biology, Crick, F. (1970). 'Central Dogma of Molecular Biology', Nature, Temin, H.M. & Mizutani, S. (1970) and Baltimore, D. (1970). Independent reverse-transcriptase discovery papers in Nature high

Core components

Sequence information transfer: DNA replication (DNA→DNA), transcription (DNA→RNA), translation (RNA→protein)
Allowed unusual transfers: reverse transcription (RNA→DNA), RNA replication (RNA→RNA)
Forbidden transfers: protein→nucleic acid sequence (the central claim)
Distinction from regulatory and post-translational processes
Foundation for contemporary molecular biology and biotechnology
Connection to genetic code (Nirenberg, Khorana decipherment 1960s)
Substantial robustness to subsequent discoveries despite added complexity

Primary use case

Foundational framework of molecular biology; conceptual backbone of contemporary biotechnology including PCR, sequencing, recombinant DNA, gene therapy, CRISPR, mRNA vaccines (Pfizer-BioNTech and Moderna COVID-19 vaccines); reference framework in molecular biology education; basis for genetic engineering, synthetic biology, and personalized medicine; foundation for substantial biomedical research; pedagogical foundation in essentially every molecular biology curriculum.

Common criticisms

Popular formulations of central dogma ('DNA makes RNA makes protein') substantially oversimplify Crick's specific claim about sequence information transfer
subsequent discoveries (alternative splicing, RNA editing, prions, epigenetic inheritance) have complicated the framework's clean exposition without falsifying its central sequence-transfer claims
Crick used the term 'dogma' apparently casually (he later wrote that he didn't realize the term implied unfalsifiable belief), and this terminology has produced confusion about whether the framework is empirical claim or assumption
tendency for popular accounts to confuse central dogma's sequence-transfer claim with broader claims about gene expression that the framework doesn't address
integration with broader epigenetic and developmental processes is genuinely complex — central dogma is one piece of a much richer molecular biology
some critics argue the framework's elegance has produced conceptual rigidity that obscured substantial subsequent complexity
rare counterexamples (prion propagation, some unusual viral systems) require careful interpretation
commercial biotechnology marketing sometimes invokes central dogma in oversimplified ways
integration with systems biology requires moving beyond linear DNA→RNA→protein framings.

Lineage

Siblings: Cell Theory, Endosymbiotic Theory